We identified three oncogenic pathways (nuclear factor-κB (NF-κB), Wnt/β-catenin, and proliferation/stem cell) that were deregulated in the vast majority (>70%) of GCs, and functionally validated the pathway predictions in vitro using a panel of GC cell lines. Here, NFKB1 is linked to gastric cancer.